Previous 10 | Next 10 |
home / stock / invvy / invvy news
Noteworthy events during the week of July 22-28 for healthcare investors. More news on: Krystal Biotech, Axsome Therapeutics, Eisai Co., Ltd. ADR, Healthcare stocks news, , Read more ...
Dr. Reddy's (NYSE: RDY ) has been denied a request to keep selling generic Suboxone by a federal judge in New Jersey. More news on: Dr. Reddy's Laboratories Limited, INDIVIOR PLC ADR, INDIVIOR PLC, Healthcare stocks news, Global news and forex, Read more ...
Aquestive Granted Preliminary Injunction WARREN, N.J. , July 16, 2018 /PRNewswire/ -- Aquestive Therapeutics ("Aquestive") announces today that the U.S. District Court for the District of New Jersey has granted Aquestive together with Indivior PLC (LON: INDV) and its U.S. subsidiar...
SLOUGH, England , July 13, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. District Court for the District of New Jersey has granted a preliminary injunction (PI) against Dr. Reddy's Laboratories (DRL). The restrictions of...
SLOUGH, England, July 11, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that its previous FY 2018 financial guidance (net revenue: $1,130m - $1,170m ; adjusted net income: $280m - $320m ) is no longer valid based on recent US...
SLOUGH, England and RICHMOND, Va. , July 10, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that it will release its half year 2018 results on July 25 th at 7:00 a.m. London time ( 2:00 a.m. U.S. EDT). The results will be available via the London Stock Exchange...
SLOUGH, England , June 28, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. District Court for the District of New Jersey heard Indivior's application for a preliminary injunction (PI) against Dr. Reddy's Laboratories (DRL). This ...
SLOUGH, England , June 15, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. District Court for the District of New Jersey has granted Indivior a temporary restraining order (TRO) that compels Dr. Reddy's (DRL) to immediate...
SLOUGH, England , June 15, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that it is aware that, on 14 June 2018 , the US FDA approved generic versions of SUBOXONE® Film from both Dr. Reddy's and Mylan, and that Dr. Reddy's subseq...
SLOUGH, England and RICHMOND, Va. , May 31, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) announced today that Indivior Inc., its wholly owned subsidiary, received a subpoena from the Office of the Insurance Commissioner for the California Department of Insurance ("CDI") on ...
News, Short Squeeze, Breakout and More Instantly...
Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance PR Newswire RICHMOND, Va. , May 23, 2024 /PRNewswire/ -- Indivior PLC (LSE: INDV; Nasdaq: INDV), a leading addiction treatment company, announced that in anticipation o...
Indivior Announces Q1 2024 Financial Results PR Newswire SLOUGH, United Kingdom and RICHMOND, Va. , April 25, 2024 /PRNewswire/ -- Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024 . The earnings re...
Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone PR Newswire This head-to-head pharmacodynamic study in healthy volunteers...